298 related articles for article (PubMed ID: 26807135)
21. Diagnostic and neuropathogenesis issues in human African trypanosomiasis.
Kennedy PG
Int J Parasitol; 2006 May; 36(5):505-12. PubMed ID: 16546191
[TBL] [Abstract][Full Text] [Related]
22. Clinical profiles, disease outcome and co-morbidities among T. b. rhodesiense sleeping sickness patients in Uganda.
Kato CD; Nanteza A; Mugasa C; Edyelu A; Matovu E; Alibu VP
PLoS One; 2015; 10(2):e0118370. PubMed ID: 25719539
[TBL] [Abstract][Full Text] [Related]
23. Identification of human-infective trypanosomes in animal reservoir of sleeping sickness in Uganda by means of serum-resistance-associated (SRA) gene.
Welburn SC; Picozzi K; Fèvre EM; Coleman PG; Odiit M; Carrington M; Maudlin I
Lancet; 2001 Dec; 358(9298):2017-9. PubMed ID: 11755607
[TBL] [Abstract][Full Text] [Related]
24. Lessons learned from the emergence of a new Trypanosoma brucei rhodesiense sleeping sickness focus in Uganda.
Hutchinson OC; Fèvre EM; Carrington M; Welburn SC
Lancet Infect Dis; 2003 Jan; 3(1):42-5. PubMed ID: 12505033
[TBL] [Abstract][Full Text] [Related]
25. Current situation of African trypanosomiasis.
Kuzoe FA
Acta Trop; 1993 Sep; 54(3-4):153-62. PubMed ID: 7902654
[TBL] [Abstract][Full Text] [Related]
26. Human African trypanosomiasis and human immunodeficiency virus co-infection in Western Kenya.
Matete GO; Kajejo OA
East Afr Med J; 2005 Jan; 82(1):20-3. PubMed ID: 16122107
[TBL] [Abstract][Full Text] [Related]
27. Current knowledge on epidemiology and control of sleeping sickness.
Kuzoe FA
Ann Soc Belg Med Trop; 1989; 69 Suppl 1():217-220. PubMed ID: 2802823
[TBL] [Abstract][Full Text] [Related]
28. Evidence for the occurrence of Trypanosoma brucei rhodesiense sleeping sickness outside the traditional focus in south-eastern Uganda.
Enyaru JC; Odiit M; Winyi-Kaboyo R; Sebikali CG; Matovu E; Okitoi D; Olaho-Mukani W
Ann Trop Med Parasitol; 1999 Dec; 93(8):817-22. PubMed ID: 10715675
[TBL] [Abstract][Full Text] [Related]
29. African trypanosomiasis in a British soldier.
Croft AM; Jackson CJ; Friend HM; Minton EJ
J R Army Med Corps; 2006 Sep; 152(3):156-60. PubMed ID: 17295013
[TBL] [Abstract][Full Text] [Related]
30. Duration of symptoms and case fatality of sleeping sickness caused by Trypanosoma brucei rhodesiense in Tororo, Uganda.
Odiit M; Kansiime F; Enyaru JC
East Afr Med J; 1997 Dec; 74(12):792-5. PubMed ID: 9557424
[TBL] [Abstract][Full Text] [Related]
31. Detection of Trypanosoma brucei rhodesiense in animals from sleeping sickness foci in East Africa using the serum resistance associated (SRA) gene.
Njiru ZK; Ndung'u K; Matete G; Ndungu JM; Gibson WC
Acta Trop; 2004 May; 90(3):249-54. PubMed ID: 15099811
[TBL] [Abstract][Full Text] [Related]
32. Application of the enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of human African trypanosomiasis (sleeping sickness).
Ruitenberg EJ; Buys J
Am J Trop Med Hyg; 1977 Jan; 26(1):31-6. PubMed ID: 320895
[TBL] [Abstract][Full Text] [Related]
33. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
Gehrig S; Efferth T
Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Procyclic Agglutination Trypanosomiasis Test (PATT) for the immunodiagnosis of Trypanosoma brucei rhodesiense sleeping sickness in Kenya.
Ngaira JM; Olaho-Mukani W; Omuse JK; Tengekyon KM; Mbwabi D; Olado D; Njenga JN
Trop Med Parasitol; 1992 Mar; 43(1):29-32. PubMed ID: 1598505
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapeutic strategies against Trypanosoma brucei: drug targets vs. drug targeting.
Lüscher A; de Koning HP; Mäser P
Curr Pharm Des; 2007; 13(6):555-67. PubMed ID: 17346174
[TBL] [Abstract][Full Text] [Related]
36. A multiplex PCR that discriminates between Trypanosoma brucei brucei and zoonotic T. b. rhodesiense.
Picozzi K; Carrington M; Welburn SC
Exp Parasitol; 2008 Jan; 118(1):41-6. PubMed ID: 17643434
[TBL] [Abstract][Full Text] [Related]
37. New biomarkers for stage determination in Trypanosoma brucei rhodesiense sleeping sickness patients.
Tiberti N; Matovu E; Hainard A; Enyaru JC; Lejon V; Robin X; Turck N; Ngoyi DM; Krishna S; Bisser S; Courtioux B; Büscher P; Kristensson K; Ndung'u JM; Sanchez JC
Clin Transl Med; 2013 Jan; 2(1):1. PubMed ID: 23369533
[TBL] [Abstract][Full Text] [Related]
38. Spatial and temporal risk factors for the early detection of Trypanosoma brucei rhodesiense sleeping sickness patients in Tororo and Busia districts, Uganda.
Odiit M; Coleman PG; McDermott JJ; Fèvre EM; Welburn SC; Woolhouse ME
Trans R Soc Trop Med Hyg; 2004 Oct; 98(10):569-76. PubMed ID: 15289093
[TBL] [Abstract][Full Text] [Related]
39. The human serum resistance associated gene is ubiquitous and conserved in Trypanosoma brucei rhodesiense throughout East Africa.
Gibson W; Backhouse T; Griffiths A
Infect Genet Evol; 2002 May; 1(3):207-14. PubMed ID: 12798017
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapy of African sleeping sickness. III. Chemotherapy of experimental Trypanosoma gambiense and Trypanosoma rhodesiense infections in mice with captostibone.
PACKCHANIAN A
Trans R Soc Trop Med Hyg; 1957 May; 51(3):257-64. PubMed ID: 13443017
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
